Protease inhibitors: their role as modifiers of carcinogenic processes.
D000818:Animals; D002273:Carcinogens; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D004249:DNA Damage; D006801:Humans; D051379:Mice; D010190:Pancreatic Neoplasms / Q000139:chemically induced*; D011480:Protease Inhibitors / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D013025:Glycine max; D013481:Superoxides / Q000633:toxicity; D014361:Trypsin Inhibitors / Q000633:toxicity
D002273:Carcinogens; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D013481:Superoxides; D002918:Chymotrypsin